BEIJING SUNBIO BIOTECH CO LTD has a total of 19 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), Hong Kong and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MORPHOTEK INC, A & G PHARMACEUTICALS INC and DEUTSCHES ZENTRUM FUER NEURODEGENERATIVE ERKRANKUNGEN E V DZNE.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Hong Kong | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | China | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Canada | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Zhu Bing | 16 |
#2 | Cui Junsheng | 9 |
#3 | Yang Shifang | 9 |
#4 | Wei Peng | 6 |
#5 | Zheng Xiangjun | 3 |
#6 | Bing Zhu | 3 |
Publication | Filing date | Title |
---|---|---|
EP2752429A1 | Fusion protein comprising circularly permuted form of trail/apo2l, coding gene and use thereof | |
WO2013029202A1 | Use of detection of aspartate aminotransferase and lactate dehydrogenase in early evaluation of clinical efficacy of anti-tumor intervention | |
EP2089053A1 | Hpv antigen fusion protein vaccine compositions and uses thereof | |
HK1098765A1 | Fusion protein containing human hsp70 atpase domain and mammalian p53 protein and the use thereof | |
ZA200604478B | A recombinant protein with cancer suppression action, its encoding gene and uses thereof | |
AU2003280921A1 | A recombinant protein with cancer suppression action, its encoding gene and use | |
KR20060088569A | A recombinant protein with cancer suppression action, its encoding gene and use |